Ustekinumab for Successful Treatment of Refractory Esophageal Crohn's Disease

被引：2
|
作者：
Barkin, Jodie A. [1 ]
Deshpande, Amar R. [1 ]
机构：
[1] Univ Miami, Leonard M Miller Sch Med, Dept Med, Div Gastroenterol, 1120 NW 14th St,Clin Res Bldg,Suite 1116 D-49, Miami, FL 33136 USA
来源：
ACG CASE REPORTS JOURNAL | 2016年 / 3卷 / 02期
关键词：
D O I：
10.14309/crj.2016.15
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Esophageal involvement in Crohn's disease is rare. We present a case of refractory esophageal Crohn's disease that responded to ustekinumab, which has shown promise in the treatment of refractory, typically intestinal Crohn's disease. There are no prior reports on the successful use of ustekinumab in esophageal Crohn's disease, but should be considered as a possible management strategy in patients with this condition.
引用
下载
收藏
页码：107 / +
页数：2
相关论文
共 50 条
  • [41] Successful treatment of a patient with Takayasu's arteritis complicated with Crohn's disease with ustekinumab: A case report
    Suga, Takeshi
    Hidaka, Yukiko
    Hori, Maisa
    Yamasaki, Hiroshi
    Wakasugi, Daisuke
    Yamasaki, Satoshi
    Yamaguchi, Rin
    Ida, Hiroaki
    Nakashima, Munetoshi
    MODERN RHEUMATOLOGY CASE REPORTS, 2023, 7 (02) : 448 - 452
  • [42] Double Biologic Therapy for Refractory Stricturing Crohn's Disease: A Successful Case of Deep Remission with Ustekinumab and Vedolizumab
    Elmoursi, Ahmed
    Barrett, Terrence A.
    Perry, Courtney
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (07) : E62 - E63
  • [43] Ustekinumab-Associated Thrombocytopenia in a Patient With Refractory Crohn's Disease
    Levine, Irving
    Rolston, Vineet
    Papademetriou, Marianna
    Malter, Lisa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S1166 - S1166
  • [44] A PILOT STUDY ON THE USE OF USTEKINUMAB IN REFRACTORY PERIANAL CROHN'S DISEASE
    Crispino, F.
    Brinch, D.
    Busacca, A.
    Carrozza, L.
    Cocorullo, G.
    Cappello, M.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S164 - S164
  • [45] Ustekinumab for Crohn's disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (01): : 9 - 9
  • [46] DEEP REMISSION WITH DOUBLE BIOLOGIC THERAPY: A SUCCESSFUL CASE OF COMBINATION USTEKINUMAB AND VEDOLIZUMAB FOR SEVERE REFRACTORY CROHN'S DISEASE
    Elmoursi, Ahmed
    Perry, Courtney
    Barrett, Terrence
    INFLAMMATORY BOWEL DISEASES, 2020, 26 : S72 - S72
  • [47] DEEP REMISSION WITH DOUBLE BIOLOGIC THERAPY: A SUCCESSFUL CASE OF COMBINATION USTEKINUMAB AND VEDOLIZUMAB FOR SEVERE REFRACTORY CROHN'S DISEASE
    Elmoursi, Ahmed
    Perry, Courtney
    Barrett, Terrence
    GASTROENTEROLOGY, 2020, 158 (03) : S117 - S118
  • [48] Successful Treatment With Ustekinumab for Chronic Refractory Pouchitis
    Tran-Minh, My-Linh
    Allez, Matthieu
    Gornet, Jean-Marc
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (09): : 1156 - 1156
  • [49] Successful Use of Ustekinumab in TNF-Inhibitior induced Psoriasis and co-existing refractory Crohn's disease
    Galli, E.
    Buening, J.
    Schmidt, E.
    Zillikens, D.
    Frambach, Y.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 74 - 74
  • [50] Successful Treatment of Refractory Autoimmune Enteropathy With Ustekinumab
    Scheid, Johannes F.
    Misdraji, Joseph
    Nath, Barbara J.
    Yarze, Joseph C.
    ACG CASE REPORTS JOURNAL, 2021, 8 (01)
12345